» Articles » PMID: 24892808

Cystic Fibrosis Airway Secretions Exhibit Mucin Hyperconcentration and Increased Osmotic Pressure

Abstract

The pathogenesis of mucoinfective lung disease in cystic fibrosis (CF) patients likely involves poor mucus clearance. A recent model of mucus clearance predicts that mucus flow depends on the relative mucin concentration of the mucus layer compared with that of the periciliary layer; however, mucin concentrations have been difficult to measure in CF secretions. Here, we have shown that the concentration of mucin in CF sputum is low when measured by immunologically based techniques, and mass spectrometric analyses of CF mucins revealed mucin cleavage at antibody recognition sites. Using physical size exclusion chromatography/differential refractometry (SEC/dRI) techniques, we determined that mucin concentrations in CF secretions were higher than those in normal secretions. Measurements of partial osmotic pressures revealed that the partial osmotic pressure of CF sputum and the retained mucus in excised CF lungs were substantially greater than the partial osmotic pressure of normal secretions. Our data reveal that mucin concentration cannot be accurately measured immunologically in proteolytically active CF secretions; mucins are hyperconcentrated in CF secretions; and CF secretion osmotic pressures predict mucus layer-dependent osmotic compression of the periciliary liquid layer in CF lungs. Consequently, mucin hypersecretion likely produces mucus stasis, which contributes to key infectious and inflammatory components of CF lung disease.

Citing Articles

Development and qualification of an LC-MS/MS method for quantification of MUC5AC and MUC5B mucins in spontaneous sputum.

Sun W, Mou S, Huntington C, Killick H, Scott I, Kelly A Bioanalysis. 2025; 17(3):187-198.

PMID: 39976267 PMC: 11853556. DOI: 10.1080/17576180.2025.2457844.


Cough in non-cystic fibrosis bronchiectasis.

Kantar A, Song W, Bush A, Chatziparasidis G ERJ Open Res. 2024; 10(6).

PMID: 39624376 PMC: 11610066. DOI: 10.1183/23120541.00330-2024.


The impact of Tanreqing injection on mucus hypersecretion and cough in bronchiectasis: A meta-analysis of randomized controlled trials.

Zhang J, Yang Z, Yuan S, Duan Y, Miao Q Medicine (Baltimore). 2024; 103(45):e40465.

PMID: 39533566 PMC: 11557049. DOI: 10.1097/MD.0000000000040465.


Impact of N-Acetylcysteine on Mucus Hypersecretion in the Airways: A Systematic Review.

Rogliani P, Manzetti G, Gholamalishahi S, Cazzola M, Calzetta L Int J Chron Obstruct Pulmon Dis. 2024; 19:2347-2360.

PMID: 39493366 PMC: 11531296. DOI: 10.2147/COPD.S474512.


Normalization of Muc5b ameliorates airway mucus plugging during persistent infection in the CFTR rat.

Murphree-Terry M, Keith J, Oden A, Birket S Am J Physiol Lung Cell Mol Physiol. 2024; 327(5):L672-L683.

PMID: 39316674 PMC: 11563644. DOI: 10.1152/ajplung.00381.2023.


References
1.
Kesimer M, Sheehan J . Analyzing the functions of large glycoconjugates through the dissipative properties of their absorbed layers using the gel-forming mucin MUC5B as an example. Glycobiology. 2008; 18(6):463-72. DOI: 10.1093/glycob/cwn024. View

2.
Cao R, Wang T, DeMaria G, Sheehan J, Kesimer M . Mapping the protein domain structures of the respiratory mucins: a mucin proteome coverage study. J Proteome Res. 2012; 11(8):4013-23. PMC: 3412937. DOI: 10.1021/pr300058z. View

3.
Thornton D, Davies J, Kirkham S, Gautrey A, Khan N, Richardson P . Identification of a nonmucin glycoprotein (gp-340) from a purified respiratory mucin preparation: evidence for an association involving the MUC5B mucin. Glycobiology. 2001; 11(11):969-77. DOI: 10.1093/glycob/11.11.969. View

4.
Fahy J, Dickey B . Airway mucus function and dysfunction. N Engl J Med. 2010; 363(23):2233-47. PMC: 4048736. DOI: 10.1056/NEJMra0910061. View

5.
Henke M, John G, Rheineck C, Chillappagari S, Naehrlich L, Rubin B . Serine proteases degrade airway mucins in cystic fibrosis. Infect Immun. 2011; 79(8):3438-44. PMC: 3147599. DOI: 10.1128/IAI.01252-10. View